Fig. 2From: Serum 14-3-3β protein: a new biomarker in asthmatic patients with acute exacerbation in an observational studyCorrelation between serum 14-3-3β levels and clinical indicators in asthmatic subgroup. A-C. Correlation between 14-3-3β and FeNO; blood Eosinophil count; FEV1/FVC; FEV1/FVC% predicted in Acute Exacerbation group of asthma; D. Correlation between 14-3-3β and FEV1 in Chronic Persistent group of asthmaBack to article page